| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.27e-22 | 46 | 45 | 12 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 7.47e-15 | 188 | 45 | 12 | GO:0005201 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 1.10e-08 | 12 | 45 | 4 | GO:0048407 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 4.26e-07 | 891 | 45 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | heparin binding | 6.98e-05 | 192 | 45 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 2.06e-04 | 51 | 45 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 3.31e-04 | 268 | 45 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | growth factor binding | 4.16e-04 | 156 | 45 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 7.72e-04 | 323 | 45 | 5 | GO:1901681 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 CARMIL2 COL17A1 LGALS3 COL1A1 | 3.65e-14 | 377 | 45 | 14 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 CARMIL2 COL17A1 LGALS3 COL1A1 | 3.78e-14 | 378 | 45 | 14 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 CARMIL2 COL17A1 LGALS3 COL1A1 | 3.92e-14 | 379 | 45 | 14 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 2.82e-10 | 76 | 45 | 7 | GO:0030199 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 9.66e-09 | 12 | 45 | 4 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 5.91e-08 | 18 | 45 | 4 | GO:0038065 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 1.94e-05 | 713 | 45 | 9 | GO:0048598 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | COL2A1 FZD1 COL4A1 COL4A2 COL5A1 TRIM71 ANGPTL6 COL12A1 WNK1 YAP1 LGALS3 COL1A1 | 5.65e-05 | 1483 | 45 | 12 | GO:0048646 |
| GeneOntologyBiologicalProcess | connective tissue development | 9.54e-05 | 343 | 45 | 6 | GO:0061448 | |
| GeneOntologyBiologicalProcess | tendon development | 9.71e-05 | 7 | 45 | 2 | GO:0035989 | |
| GeneOntologyBiologicalProcess | embryo development | COL2A1 FZD1 HOXA4 COL5A1 TRIM71 KMT2D COL11A1 COL12A1 WNK1 YAP1 COL1A1 | 2.02e-04 | 1437 | 45 | 11 | GO:0009790 |
| GeneOntologyBiologicalProcess | circulatory system development | COL2A1 FZD1 COL4A1 COL4A2 COL5A1 ANGPTL6 COL11A1 WNK1 YAP1 LGALS3 COL1A1 | 2.08e-04 | 1442 | 45 | 11 | GO:0072359 |
| GeneOntologyBiologicalProcess | embryonic skeletal system development | 3.02e-04 | 148 | 45 | 4 | GO:0048706 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 3.32e-04 | 277 | 45 | 5 | GO:0048705 | |
| GeneOntologyBiologicalProcess | regulation of canonical Wnt signaling pathway | 3.78e-04 | 285 | 45 | 5 | GO:0060828 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription | 5.48e-04 | 16 | 45 | 2 | GO:0006369 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 6.49e-04 | 321 | 45 | 5 | GO:0003007 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 6.82e-04 | 906 | 45 | 8 | GO:0043009 | |
| GeneOntologyCellularComponent | collagen trimer | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COLEC12 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 WDR33 COL1A1 | 2.79e-23 | 88 | 45 | 14 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL1A1 | 1.22e-19 | 21 | 45 | 9 | GO:0098644 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COLEC12 COL5A3 ANGPTL6 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 LGALS3 ANXA11 COL1A1 | 7.65e-15 | 530 | 45 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 6.44e-14 | 12 | 45 | 6 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 6.44e-14 | 12 | 45 | 6 | GO:0098643 | |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COLEC12 COL5A3 ANGPTL6 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 LGALS3 ANXA11 COL1A1 | 2.05e-13 | 656 | 45 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COLEC12 COL5A3 ANGPTL6 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 LGALS3 ANXA11 COL1A1 | 2.15e-13 | 658 | 45 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 3.80e-12 | 332 | 45 | 12 | GO:0005788 |
| GeneOntologyCellularComponent | collagen type XI trimer | 9.35e-11 | 5 | 45 | 4 | GO:0005592 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.86e-07 | 6 | 45 | 3 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane | 2.36e-07 | 122 | 45 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 5.18e-07 | 8 | 45 | 3 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 5.18e-07 | 8 | 45 | 3 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 5.18e-07 | 8 | 45 | 3 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen type V trimer | 2.71e-05 | 4 | 45 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 6.76e-05 | 6 | 45 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL1A1 | 8.26e-04 | 1187 | 45 | 9 | GO:0099081 |
| GeneOntologyCellularComponent | mRNA cleavage factor complex | 2.03e-03 | 31 | 45 | 2 | GO:0005849 | |
| GeneOntologyCellularComponent | immunological synapse | 5.00e-03 | 49 | 45 | 2 | GO:0001772 | |
| HumanPheno | Atrophic scars | 2.86e-07 | 37 | 21 | 5 | HP:0001075 | |
| HumanPheno | Degenerative vitreoretinopathy | 6.01e-07 | 5 | 21 | 3 | HP:0007964 | |
| HumanPheno | Dumbbell-shaped long bone | 2.09e-06 | 7 | 21 | 3 | HP:0000947 | |
| HumanPheno | Osteoarthritis | 5.03e-06 | 65 | 21 | 5 | HP:0002758 | |
| HumanPheno | Cigarette-paper scars | 7.12e-06 | 10 | 21 | 3 | HP:0001073 | |
| HumanPheno | Bell-shaped thorax | 8.09e-06 | 33 | 21 | 4 | HP:0001591 | |
| HumanPheno | Atypical scarring of skin | 9.58e-06 | 74 | 21 | 5 | HP:0000987 | |
| HumanPheno | Hypoplastic ischia | 3.27e-05 | 16 | 21 | 3 | HP:0003175 | |
| HumanPheno | Scarring | 4.60e-05 | 102 | 21 | 5 | HP:0100699 | |
| HumanPheno | Dilatation of the cerebral artery | 4.71e-05 | 51 | 21 | 4 | HP:0004944 | |
| HumanPheno | Subcutaneous spheroids | 4.84e-05 | 3 | 21 | 2 | HP:0025014 | |
| HumanPheno | Dermal atrophy | 5.80e-05 | 107 | 21 | 5 | HP:0004334 | |
| HumanPheno | Joint laxity | 6.35e-05 | 55 | 21 | 4 | HP:0001388 | |
| HumanPheno | Limb pain | 7.32e-05 | 57 | 21 | 4 | HP:0009763 | |
| HumanPheno | Vitreoretinopathy | 8.84e-05 | 22 | 21 | 3 | HP:0007773 | |
| HumanPheno | Retinal detachment | 9.26e-05 | 118 | 21 | 5 | HP:0000541 | |
| HumanPheno | short, dumbbell appearance of long bones | 9.67e-05 | 4 | 21 | 2 | HP:0005061 | |
| HumanPheno | Dumbbell-shaped femur | 9.67e-05 | 4 | 21 | 2 | HP:0006375 | |
| HumanPheno | Cervical insufficiency | 9.67e-05 | 4 | 21 | 2 | HP:0030009 | |
| HumanPheno | Piezogenic pedal papules | 9.67e-05 | 4 | 21 | 2 | HP:0025509 | |
| HumanPheno | Abnormality of the distal femoral epiphysis | 9.67e-05 | 4 | 21 | 2 | HP:0010590 | |
| HumanPheno | Incisional hernia | 9.67e-05 | 4 | 21 | 2 | HP:0004872 | |
| HumanPheno | Abnormality of tibial epiphyses | 1.61e-04 | 5 | 21 | 2 | HP:0006508 | |
| HumanPheno | Abnormal ischium morphology | 1.66e-04 | 27 | 21 | 3 | HP:0003174 | |
| HumanPheno | Cupped ribs | 2.06e-04 | 29 | 21 | 3 | HP:0000887 | |
| HumanPheno | Short scapulae | 2.28e-04 | 30 | 21 | 3 | HP:0000906 | |
| HumanPheno | Hypoplastic scapulae | 2.28e-04 | 30 | 21 | 3 | HP:0000882 | |
| HumanPheno | Short femur | 2.52e-04 | 31 | 21 | 3 | HP:0003097 | |
| HumanPheno | Aplasia/Hypoplasia of the scapulae | 2.52e-04 | 31 | 21 | 3 | HP:0006713 | |
| HumanPheno | Joint subluxation | 2.52e-04 | 31 | 21 | 3 | HP:0032153 | |
| HumanPheno | Glossoptosis | 2.77e-04 | 32 | 21 | 3 | HP:0000162 | |
| HumanPheno | Pierre-Robin sequence | 3.33e-04 | 34 | 21 | 3 | HP:0000201 | |
| HumanPheno | Pulp calcification | 3.36e-04 | 7 | 21 | 2 | HP:0003771 | |
| HumanPheno | Congenital bilateral hip dislocation | 3.36e-04 | 7 | 21 | 2 | HP:0008780 | |
| HumanPheno | Lens luxation | 3.36e-04 | 7 | 21 | 2 | HP:0012019 | |
| HumanPheno | Phalangeal dislocation | 3.36e-04 | 7 | 21 | 2 | HP:0006243 | |
| HumanPheno | Molluscoid pseudotumors | 3.36e-04 | 7 | 21 | 2 | HP:0000993 | |
| HumanPheno | Uterine prolapse | 3.36e-04 | 7 | 21 | 2 | HP:0000139 | |
| HumanPheno | Abnormal femoral epiphysis morphology | 3.64e-04 | 86 | 21 | 4 | HP:0006499 | |
| HumanPheno | Fragile skin | 4.29e-04 | 37 | 21 | 3 | HP:0001030 | |
| HumanPheno | Genital hernia | 4.47e-04 | 8 | 21 | 2 | HP:0100823 | |
| HumanPheno | Arterial rupture | 4.47e-04 | 8 | 21 | 2 | HP:0025019 | |
| HumanPheno | Blepharochalasis | 4.47e-04 | 8 | 21 | 2 | HP:0010749 | |
| HumanPheno | Bifid uvula | 4.74e-04 | 167 | 21 | 5 | HP:0000193 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 5.12e-04 | 94 | 21 | 4 | HP:0006500 | |
| HumanPheno | Enlarged thorax | 5.12e-04 | 94 | 21 | 4 | HP:0100625 | |
| HumanPheno | Tibial bowing | 5.82e-04 | 41 | 21 | 3 | HP:0002982 | |
| HumanPheno | Vertebral clefting | 5.82e-04 | 41 | 21 | 3 | HP:0008428 | |
| HumanPheno | Abnormal hip bone morphology | COL2A1 COL5A1 KMT2D COL11A1 COL11A2 COL12A1 ATN1 WNK1 COL1A1 | 6.19e-04 | 653 | 21 | 9 | HP:0003272 |
| HumanPheno | Muscle spasm | 6.35e-04 | 178 | 21 | 5 | HP:0003394 | |
| HumanPheno | Abnormal middle ear morphology | 6.61e-04 | 390 | 21 | 7 | HP:0008609 | |
| HumanPheno | Lens dislocation | 6.70e-04 | 43 | 21 | 3 | HP:0000665 | |
| HumanPheno | Ectopia lentis | 6.70e-04 | 43 | 21 | 3 | HP:0001083 | |
| HumanPheno | Abnormal scapula morphology | 6.86e-04 | 181 | 21 | 5 | HP:0000782 | |
| HumanPheno | Premature osteoarthritis | 7.14e-04 | 10 | 21 | 2 | HP:0003088 | |
| HumanPheno | Schizencephaly | 7.14e-04 | 10 | 21 | 2 | HP:0010636 | |
| HumanPheno | Irregular femoral epiphysis | 7.14e-04 | 10 | 21 | 2 | HP:0006361 | |
| HumanPheno | Soft skin | 7.18e-04 | 44 | 21 | 3 | HP:0000977 | |
| HumanPheno | Abnormal tibia morphology | 8.36e-04 | 107 | 21 | 4 | HP:0002992 | |
| HumanPheno | Blue sclerae | 8.66e-04 | 108 | 21 | 4 | HP:0000592 | |
| HumanPheno | Protuberant abdomen | 8.72e-04 | 47 | 21 | 3 | HP:0001538 | |
| HumanPheno | Abnormal patella morphology | 8.97e-04 | 109 | 21 | 4 | HP:0003045 | |
| HumanPheno | Generalized joint hypermobility | 9.27e-04 | 48 | 21 | 3 | HP:0002761 | |
| HumanPheno | Abnormal vitreous humor morphology | 9.85e-04 | 49 | 21 | 3 | HP:0004327 | |
| HumanPheno | Abnormal uvula morphology | 1.01e-03 | 197 | 21 | 5 | HP:0000172 | |
| HumanPheno | Arterial dissection | 1.04e-03 | 12 | 21 | 2 | HP:0005294 | |
| HumanPheno | Dermatochalasis | 1.04e-03 | 12 | 21 | 2 | HP:0010750 | |
| HumanPheno | Arteriovenous fistula | 1.04e-03 | 12 | 21 | 2 | HP:0004947 | |
| HumanPheno | Joint hypermobility | 1.08e-03 | 557 | 21 | 8 | HP:0001382 | |
| HumanPheno | Aplasia/Hypoplasia of the skin | 1.10e-03 | 201 | 21 | 5 | HP:0008065 | |
| HumanPheno | Finger joint hypermobility | 1.17e-03 | 52 | 21 | 3 | HP:0006094 | |
| HumanPheno | Thin ribs | 1.17e-03 | 52 | 21 | 3 | HP:0000883 | |
| HumanPheno | Poor wound healing | 1.17e-03 | 52 | 21 | 3 | HP:0001058 | |
| HumanPheno | Enlarged joints | 1.23e-03 | 13 | 21 | 2 | HP:0003037 | |
| HumanPheno | Spondyloepiphyseal dysplasia | 1.23e-03 | 13 | 21 | 2 | HP:0002655 | |
| HumanPheno | Abnormal uterine cervix morphology | 1.23e-03 | 13 | 21 | 2 | HP:0012888 | |
| HumanPheno | Arthralgia | 1.26e-03 | 207 | 21 | 5 | HP:0002829 | |
| HumanPheno | Abnormal pelvic girdle bone morphology | COL2A1 COL5A1 KMT2D COL11A1 COL11A2 COL12A1 ATN1 WNK1 COL1A1 | 1.41e-03 | 730 | 21 | 9 | HP:0002644 |
| HumanPheno | Tricuspid valve prolapse | 1.43e-03 | 14 | 21 | 2 | HP:0001704 | |
| HumanPheno | Neonatal short-limb short stature | 1.43e-03 | 14 | 21 | 2 | HP:0008921 | |
| HumanPheno | Soft, doughy skin | 1.43e-03 | 14 | 21 | 2 | HP:0001027 | |
| HumanPheno | Platyspondyly | 1.45e-03 | 124 | 21 | 4 | HP:0000926 | |
| HumanPheno | Myopia | 1.50e-03 | 447 | 21 | 7 | HP:0000545 | |
| HumanPheno | Abnormality of hand joint mobility | 1.53e-03 | 57 | 21 | 3 | HP:0006256 | |
| HumanPheno | Abnormal cornea morphology | 1.62e-03 | 744 | 21 | 9 | HP:0000481 | |
| HumanPheno | Knee osteoarthritis | 1.65e-03 | 15 | 21 | 2 | HP:0005086 | |
| HumanPheno | Enlarged epiphyses | 1.65e-03 | 15 | 21 | 2 | HP:0010580 | |
| MousePheno | abnormal joint mobility | 9.55e-06 | 17 | 35 | 3 | MP:0008069 | |
| MousePheno | abnormal synovial joint morphology | 1.33e-05 | 124 | 35 | 5 | MP:0030804 | |
| MousePheno | buphthalmos | 3.64e-05 | 4 | 35 | 2 | MP:0009274 | |
| MousePheno | abnormal bone marrow cavity morphology | 4.04e-05 | 27 | 35 | 3 | MP:0000065 | |
| MousePheno | anterior polar cataract | 6.06e-05 | 5 | 35 | 2 | MP:0010259 | |
| MousePheno | abnormal skin tensile strength | 6.79e-05 | 32 | 35 | 3 | MP:0005275 | |
| MousePheno | micromelia | 9.08e-05 | 6 | 35 | 2 | MP:0008736 | |
| MousePheno | polar cataract | 9.08e-05 | 6 | 35 | 2 | MP:0010258 | |
| MousePheno | decreased bone strength | 1.14e-04 | 38 | 35 | 3 | MP:0004991 | |
| MousePheno | podocyte foot process effacement | 1.14e-04 | 38 | 35 | 3 | MP:0008140 | |
| MousePheno | macrophthalmia | 1.69e-04 | 8 | 35 | 2 | MP:0001296 | |
| MousePheno | prominent forehead | 1.69e-04 | 8 | 35 | 2 | MP:0030049 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 1.77e-04 | 44 | 35 | 3 | MP:0011348 | |
| MousePheno | abnormal hyaline cartilage morphology | 2.03e-04 | 46 | 35 | 3 | MP:0006429 | |
| MousePheno | dilated glomerular capillary | 2.17e-04 | 9 | 35 | 2 | MP:0011509 | |
| MousePheno | decreased neuronal stem cell self-renewal | 2.17e-04 | 9 | 35 | 2 | MP:0012207 | |
| MousePheno | decreased circulating protein level | 2.63e-04 | 698 | 35 | 8 | MP:0014502 | |
| MousePheno | decreased bone mineralization | 2.76e-04 | 51 | 35 | 3 | MP:0020137 | |
| MousePheno | decreased collagen level | 3.30e-04 | 11 | 35 | 2 | MP:0020254 | |
| MousePheno | abnormal podocyte foot process morphology | 3.45e-04 | 55 | 35 | 3 | MP:0008059 | |
| MousePheno | abnormal joint morphology | 4.08e-04 | 397 | 35 | 6 | MP:0002932 | |
| MousePheno | dilated capillary | 4.67e-04 | 13 | 35 | 2 | MP:0020326 | |
| MousePheno | total cataract | 4.67e-04 | 13 | 35 | 2 | MP:0010263 | |
| MousePheno | abnormal articular cartilage morphology | 5.44e-04 | 14 | 35 | 2 | MP:0006433 | |
| MousePheno | abnormal neuronal stem cell self-renewal | 5.44e-04 | 14 | 35 | 2 | MP:0012205 | |
| MousePheno | increased granulocyte number | 5.92e-04 | 597 | 35 | 7 | MP:0000322 | |
| MousePheno | abnormal axial skeleton morphology | COL2A1 HOXA4 COL4A2 TRIM71 KMT2D COL11A1 COL11A2 COL12A1 FHIP1B LGALS3 COL1A1 | 5.97e-04 | 1458 | 35 | 11 | MP:0002114 |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 7.02e-04 | 70 | 35 | 3 | MP:0011497 | |
| MousePheno | abnormal podocyte morphology | 7.02e-04 | 70 | 35 | 3 | MP:0005326 | |
| MousePheno | abnormal collagen level | 7.15e-04 | 16 | 35 | 2 | MP:0020252 | |
| MousePheno | decreased diameter of femur | 7.15e-04 | 16 | 35 | 2 | MP:0008152 | |
| MousePheno | abnormal neuronal stem cell physiology | 7.15e-04 | 16 | 35 | 2 | MP:0012204 | |
| MousePheno | abnormal skeleton development | 7.63e-04 | 447 | 35 | 6 | MP:0002113 | |
| MousePheno | abnormal forehead shape | 8.09e-04 | 17 | 35 | 2 | MP:0030045 | |
| MousePheno | abnormal bone strength | 8.25e-04 | 74 | 35 | 3 | MP:0001542 | |
| MousePheno | abnormal long bone epiphyseal plate morphology | 8.60e-04 | 172 | 35 | 4 | MP:0003055 | |
| MousePheno | abnormal cartilage development | 8.60e-04 | 172 | 35 | 4 | MP:0000164 | |
| MousePheno | abnormal compact bone morphology | 8.60e-04 | 172 | 35 | 4 | MP:0003797 | |
| MousePheno | abnormal thoracic cage morphology | 9.16e-04 | 463 | 35 | 6 | MP:0004624 | |
| MousePheno | small vertebral body | 1.01e-03 | 19 | 35 | 2 | MP:0004670 | |
| MousePheno | hematuria | 1.01e-03 | 19 | 35 | 2 | MP:0005161 | |
| MousePheno | increased inflammatory response | COL4A1 FOXO3 COL4A5 COL11A1 COL17A1 YAP1 RAB26 LGALS3 COL1A1 | 1.04e-03 | 1077 | 35 | 9 | MP:0001846 |
| MousePheno | lens vacuoles | 1.12e-03 | 20 | 35 | 2 | MP:0011697 | |
| MousePheno | abnormal lens capsule morphology | 1.12e-03 | 20 | 35 | 2 | MP:0003236 | |
| MousePheno | abnormal epiphyseal plate morphology | 1.13e-03 | 185 | 35 | 4 | MP:0006395 | |
| MousePheno | abnormal eye development | 1.13e-03 | 482 | 35 | 6 | MP:0001286 | |
| MousePheno | abnormal chondrocyte morphology | 1.15e-03 | 83 | 35 | 3 | MP:0000166 | |
| MousePheno | osteoarthritis | 1.24e-03 | 21 | 35 | 2 | MP:0003560 | |
| MousePheno | abnormal anterior eye segment morphology | 1.35e-03 | 1117 | 35 | 9 | MP:0005193 | |
| MousePheno | abnormal appendicular skeleton morphology | 1.38e-03 | 896 | 35 | 8 | MP:0009250 | |
| MousePheno | abnormal cartilage morphology | 1.40e-03 | 336 | 35 | 5 | MP:0000163 | |
| MousePheno | decreased erythrocyte cell number | 1.47e-03 | 340 | 35 | 5 | MP:0002875 | |
| MousePheno | decreased diameter of long bones | 1.49e-03 | 23 | 35 | 2 | MP:0008150 | |
| MousePheno | abnormal lens morphology | 1.50e-03 | 699 | 35 | 7 | MP:0001303 | |
| MousePheno | abnormal nose morphology | 1.53e-03 | 201 | 35 | 4 | MP:0002233 | |
| MousePheno | decreased bone trabecular spacing | 1.62e-03 | 24 | 35 | 2 | MP:0013631 | |
| MousePheno | abnormal forehead morphology | 1.62e-03 | 24 | 35 | 2 | MP:0030031 | |
| MousePheno | urinary bladder obstruction | 1.76e-03 | 25 | 35 | 2 | MP:0009552 | |
| MousePheno | abnormal limb joint morphology | 1.76e-03 | 25 | 35 | 2 | MP:0030805 | |
| MousePheno | disorganized long bone epiphyseal plate | 1.76e-03 | 25 | 35 | 2 | MP:0006397 | |
| Domain | Collagen | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COLEC12 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 WDR33 COL1A1 | 7.91e-23 | 85 | 45 | 14 | PF01391 |
| Domain | Collagen | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COLEC12 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 WDR33 COL1A1 | 7.91e-23 | 85 | 45 | 14 | IPR008160 |
| Domain | NC1_FIB | 6.33e-14 | 11 | 45 | 6 | PS51461 | |
| Domain | Fib_collagen_C | 6.33e-14 | 11 | 45 | 6 | IPR000885 | |
| Domain | Fib_collagen_C | 6.33e-14 | 11 | 45 | 6 | PD002078 | |
| Domain | COLFI | 6.33e-14 | 11 | 45 | 6 | SM00038 | |
| Domain | COLFI | 6.33e-14 | 11 | 45 | 6 | PF01410 | |
| Domain | TSPN | 1.35e-11 | 23 | 45 | 6 | SM00210 | |
| Domain | - | 2.73e-09 | 95 | 45 | 7 | 2.60.120.200 | |
| Domain | Laminin_G | 5.10e-09 | 58 | 45 | 6 | IPR001791 | |
| Domain | C4 | 2.60e-07 | 6 | 45 | 3 | SM00111 | |
| Domain | - | 2.60e-07 | 6 | 45 | 3 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.60e-07 | 6 | 45 | 3 | IPR001442 | |
| Domain | NC1_IV | 2.60e-07 | 6 | 45 | 3 | PS51403 | |
| Domain | C4 | 2.60e-07 | 6 | 45 | 3 | PF01413 | |
| Domain | ConA-like_dom | 8.61e-07 | 219 | 45 | 7 | IPR013320 | |
| Domain | HMGI/Y_DNA-bd_CS | 8.82e-07 | 31 | 45 | 4 | IPR000637 | |
| Domain | Laminin_G_2 | 2.52e-06 | 40 | 45 | 4 | PF02210 | |
| Domain | LamG | 3.72e-06 | 44 | 45 | 4 | SM00282 | |
| Domain | CTDL_fold | 1.27e-04 | 107 | 45 | 4 | IPR016187 | |
| Domain | VWC | 2.06e-03 | 28 | 45 | 2 | PF00093 | |
| Domain | VWFC_1 | 3.39e-03 | 36 | 45 | 2 | PS01208 | |
| Domain | VWC | 3.78e-03 | 38 | 45 | 2 | SM00214 | |
| Domain | VWFC_2 | 3.78e-03 | 38 | 45 | 2 | PS50184 | |
| Domain | VWF_dom | 4.60e-03 | 42 | 45 | 2 | IPR001007 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 4.93e-23 | 41 | 35 | 12 | MM15538 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.31e-22 | 44 | 35 | 12 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.05e-20 | 61 | 35 | 12 | MM14637 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.98e-20 | 64 | 35 | 12 | M26953 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 3.60e-20 | 67 | 35 | 12 | M26999 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.84e-19 | 76 | 35 | 12 | MM14573 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL17A1 COL1A1 | 1.48e-18 | 61 | 35 | 11 | M27103 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.59e-18 | 90 | 35 | 12 | M631 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 8.29e-18 | 46 | 35 | 10 | M198 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL1A1 | 2.08e-17 | 50 | 35 | 10 | MM14796 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL1A1 | 3.15e-17 | 32 | 35 | 9 | MM14924 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL1A1 | 3.92e-17 | 53 | 35 | 10 | MM14566 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 3.91e-16 | 140 | 35 | 12 | M587 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.40e-15 | 74 | 35 | 10 | M160 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL1A1 | 1.35e-14 | 59 | 35 | 9 | M27218 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL1A1 | 1.24e-13 | 114 | 35 | 10 | MM14571 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 6.28e-13 | 258 | 35 | 12 | MM14572 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 3.74e-12 | 300 | 35 | 12 | M610 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.95e-12 | 19 | 35 | 6 | MM15512 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 5.64e-12 | 20 | 35 | 6 | MM15061 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.02e-11 | 76 | 35 | 8 | MM14867 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.33e-11 | 84 | 35 | 8 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.57e-11 | 85 | 35 | 8 | M16441 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 8.48e-11 | 30 | 35 | 6 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 8.48e-11 | 30 | 35 | 6 | MM15517 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.16e-10 | 66 | 35 | 7 | M18 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.89e-10 | 38 | 35 | 6 | MM14969 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.95e-10 | 76 | 35 | 7 | M27219 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 6.30e-10 | 41 | 35 | 6 | M27778 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 7.34e-10 | 42 | 35 | 6 | M7169 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 4.94e-09 | 57 | 35 | 6 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 5.50e-09 | 58 | 35 | 6 | M2049 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 9.16e-09 | 63 | 35 | 6 | M11187 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.34e-08 | 67 | 35 | 6 | MM15345 | |
| Pathway | WP_FOCAL_ADHESION | 1.43e-08 | 187 | 35 | 8 | MM15913 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.33e-08 | 199 | 35 | 8 | M7253 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.64e-08 | 79 | 35 | 6 | M27643 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | COL2A1 COL4A1 COL4A2 FOXO3 COL5A1 COL5A3 COL11A1 COL11A2 COL1A1 | 3.65e-08 | 302 | 35 | 9 | M39719 |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 4.26e-08 | 15 | 35 | 4 | M27161 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 YAP1 COL1A1 | 4.46e-08 | 418 | 35 | 10 | MM15587 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | COL2A1 COL4A1 COL4A2 FOXO3 COL5A1 COL5A3 COL11A1 COL11A2 COL1A1 | 7.04e-08 | 326 | 35 | 9 | MM15917 |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 9.50e-08 | 18 | 35 | 4 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 9.50e-08 | 18 | 35 | 4 | MM14882 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 1.20e-07 | 19 | 35 | 4 | M27221 | |
| Pathway | WP_SPINAL_CORD_INJURY | 3.83e-07 | 117 | 35 | 6 | M39341 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 YAP1 COL1A1 | 4.22e-07 | 532 | 35 | 10 | M27870 |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.66e-06 | 10 | 35 | 3 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.66e-06 | 10 | 35 | 3 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.28e-06 | 11 | 35 | 3 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 3.04e-06 | 12 | 35 | 3 | MM1526 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 3.67e-06 | 43 | 35 | 4 | M39565 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 3.94e-06 | 13 | 35 | 3 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 3.94e-06 | 13 | 35 | 3 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 5.01e-06 | 14 | 35 | 3 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 5.01e-06 | 14 | 35 | 3 | M6487 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.26e-06 | 47 | 35 | 4 | MM14925 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 6.25e-06 | 15 | 35 | 3 | MM14922 | |
| Pathway | WP_SPINAL_CORD_INJURY | 6.50e-06 | 108 | 35 | 5 | MM15954 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 1.12e-05 | 18 | 35 | 3 | M39421 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.55e-05 | 20 | 35 | 3 | M15394 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.40e-05 | 23 | 35 | 3 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.40e-05 | 23 | 35 | 3 | MM1427 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.93e-05 | 261 | 35 | 6 | MM15676 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 3.94e-05 | 27 | 35 | 3 | M27217 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 4.40e-05 | 28 | 35 | 3 | MM15957 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 5.44e-05 | 30 | 35 | 3 | M27216 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 8.55e-05 | 439 | 35 | 7 | M42563 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 9.75e-05 | 98 | 35 | 4 | M27152 | |
| Pathway | WP_FOCAL_ADHESION | 1.23e-04 | 199 | 35 | 5 | M39402 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.62e-04 | 43 | 35 | 3 | M53 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.67e-04 | 339 | 35 | 6 | M39736 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.97e-04 | 502 | 35 | 7 | MM14537 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 4.50e-04 | 575 | 35 | 7 | M29853 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 HOXA4 COL4A1 COL4A2 FOXO3 TPRX1 COL4A5 COL5A1 COL5A3 KMT2D YAP1 | 4.76e-04 | 1432 | 35 | 11 | M509 |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 6.51e-04 | 161 | 35 | 4 | M39770 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 7.96e-04 | 17 | 35 | 2 | M48025 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 1.11e-03 | 20 | 35 | 2 | M497 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 1.11e-03 | 20 | 35 | 2 | MM15469 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 1.21e-03 | 190 | 35 | 4 | M8240 | |
| Pathway | REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION | 1.60e-03 | 24 | 35 | 2 | M27803 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.71e-03 | 96 | 35 | 3 | M39834 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 2.33e-03 | 29 | 35 | 2 | M783 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 2.33e-03 | 29 | 35 | 2 | MM15444 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 2.66e-03 | 31 | 35 | 2 | M27805 | |
| Pathway | WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA | 3.01e-03 | 33 | 35 | 2 | M39870 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2 | 3.15e-03 | 119 | 35 | 3 | M27785 | |
| Pathway | WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS | 3.38e-03 | 35 | 35 | 2 | M39430 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 4.49e-03 | 135 | 35 | 3 | MM14781 | |
| Pathway | PID_DELTA_NP63_PATHWAY | 6.04e-03 | 47 | 35 | 2 | M236 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 6.81e-03 | 50 | 35 | 2 | M48087 | |
| Pathway | WP_NETRINUNC5B_SIGNALING | 7.35e-03 | 52 | 35 | 2 | M39782 | |
| Pathway | WP_PREIMPLANTATION_EMBRYO | 9.38e-03 | 59 | 35 | 2 | M39579 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 1.03e-02 | 62 | 35 | 2 | MM15426 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A2 COL16A1 COL17A1 ANXA11 COL1A1 | 3.74e-21 | 62 | 47 | 11 | 28344315 |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 LGALS3 COL1A1 | 3.30e-19 | 135 | 47 | 12 | 28675934 |
| Pubmed | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 ANXA11 COL1A1 | 8.06e-18 | 175 | 47 | 12 | 28071719 | |
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 1.22e-16 | 8 | 47 | 6 | 20059976 | |
| Pubmed | COL4A1 COL4A2 COL4A5 COL5A1 COLEC12 COL5A3 COL12A1 COL16A1 LGALS3 ANXA11 COL1A1 | 3.36e-16 | 167 | 47 | 11 | 22159717 | |
| Pubmed | 3.54e-16 | 39 | 47 | 8 | 33580754 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | COL2A1 COL4A1 COL4A2 COL5A1 COL11A1 COL12A1 COL16A1 LGALS3 COL1A1 | 2.83e-15 | 86 | 47 | 9 | 28327460 |
| Pubmed | COL4A1 COL4A2 COL5A1 ANGPTL6 COL12A1 COL16A1 COL17A1 LGALS3 ANXA11 COL1A1 | 9.07e-15 | 153 | 47 | 10 | 25037231 | |
| Pubmed | 2.17e-14 | 6 | 47 | 5 | 21467034 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 2.17e-14 | 6 | 47 | 5 | 8563024 | |
| Pubmed | Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse. | 2.93e-12 | 4 | 47 | 4 | 17683922 | |
| Pubmed | 2.93e-12 | 4 | 47 | 4 | 27588265 | ||
| Pubmed | 2.93e-12 | 4 | 47 | 4 | 23624467 | ||
| Pubmed | 2.93e-12 | 4 | 47 | 4 | 2851479 | ||
| Pubmed | 2.18e-11 | 146 | 47 | 8 | 27068509 | ||
| Pubmed | 4.15e-11 | 19 | 47 | 5 | 15689378 | ||
| Pubmed | 4.38e-11 | 6 | 47 | 4 | 10722718 | ||
| Pubmed | 4.38e-11 | 6 | 47 | 4 | 2993301 | ||
| Pubmed | 4.38e-11 | 6 | 47 | 4 | 17876790 | ||
| Pubmed | Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. | 4.38e-11 | 6 | 47 | 4 | 3571333 | |
| Pubmed | The molecular chaperone Hsp47 is essential for cartilage and endochondral bone formation. | 4.38e-11 | 6 | 47 | 4 | 22492985 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 6.05e-11 | 97 | 47 | 7 | 27559042 | |
| Pubmed | 6.64e-11 | 50 | 47 | 6 | 23658023 | ||
| Pubmed | 1.88e-10 | 25 | 47 | 5 | 19180518 | ||
| Pubmed | 2.04e-10 | 8 | 47 | 4 | 3997552 | ||
| Pubmed | 2.04e-10 | 8 | 47 | 4 | 1377218 | ||
| Pubmed | 2.04e-10 | 8 | 47 | 4 | 18816857 | ||
| Pubmed | 2.04e-10 | 8 | 47 | 4 | 10382266 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 2.04e-10 | 8 | 47 | 4 | 10970885 | |
| Pubmed | 3.67e-10 | 9 | 47 | 4 | 9878537 | ||
| Pubmed | 3.67e-10 | 9 | 47 | 4 | 8900172 | ||
| Pubmed | COL2A1 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 | 3.97e-10 | 210 | 47 | 8 | 16537572 | |
| Pubmed | 6.11e-10 | 10 | 47 | 4 | 9415455 | ||
| Pubmed | 6.11e-10 | 10 | 47 | 4 | 2446864 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 1.44e-09 | 12 | 47 | 4 | 12180907 | |
| Pubmed | 2.07e-09 | 13 | 47 | 4 | 25746793 | ||
| Pubmed | Molecular genetics of human salivary proteins and their polymorphisms. | 2.31e-09 | 3 | 47 | 3 | 3055850 | |
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 17024418 | ||
| Pubmed | The structure and evolution of the human salivary proline-rich protein gene family. | 2.31e-09 | 3 | 47 | 3 | 8422499 | |
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 34009784 | ||
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 15908193 | ||
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 15141750 | ||
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 36553626 | ||
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 3.95e-09 | 15 | 47 | 4 | 9832566 | |
| Pubmed | 5.26e-09 | 16 | 47 | 4 | 17881772 | ||
| Pubmed | Maturational disturbance of chondrocytes in Cbfa1-deficient mice. | 6.88e-09 | 17 | 47 | 4 | 10213384 | |
| Pubmed | 9.24e-09 | 4 | 47 | 3 | 29068597 | ||
| Pubmed | 9.24e-09 | 4 | 47 | 3 | 1339347 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 9409248 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 26375204 | ||
| Pubmed | 3.05e-08 | 24 | 47 | 4 | 25344368 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 4.25e-08 | 248 | 47 | 7 | 24006456 | |
| Pubmed | Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. | 4.28e-08 | 26 | 47 | 4 | 21367821 | |
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 4.61e-08 | 6 | 47 | 3 | 9506531 | |
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 7495302 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 4.61e-08 | 6 | 47 | 3 | 17029294 | |
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 2426947 | ||
| Pubmed | Retarded skeletal development in transgenic mice with a type II collagen mutation. | 4.61e-08 | 6 | 47 | 3 | 8952549 | |
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 4.61e-08 | 6 | 47 | 3 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 4.61e-08 | 6 | 47 | 3 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 4.61e-08 | 6 | 47 | 3 | 6389236 | |
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 16192629 | ||
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 12225806 | ||
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 20301479 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 4.61e-08 | 6 | 47 | 3 | 10534397 | |
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 9101290 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 4.61e-08 | 6 | 47 | 3 | 9673377 | |
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 15922184 | ||
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 4.61e-08 | 6 | 47 | 3 | 19275937 | |
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 6988303 | ||
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 5.02e-08 | 27 | 47 | 4 | 12192060 | |
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 10639489 | ||
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 8.06e-08 | 7 | 47 | 3 | 8006028 | |
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 10416788 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 8.06e-08 | 7 | 47 | 3 | 10716744 | |
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 1724753 | ||
| Pubmed | Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. | 8.06e-08 | 7 | 47 | 3 | 9334230 | |
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 12847218 | ||
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 7521231 | ||
| Pubmed | 1.02e-07 | 32 | 47 | 4 | 23154389 | ||
| Pubmed | 1.29e-07 | 8 | 47 | 3 | 29422532 | ||
| Pubmed | 1.29e-07 | 8 | 47 | 3 | 15872058 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 1.29e-07 | 8 | 47 | 3 | 11867580 | |
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 1.29e-07 | 8 | 47 | 3 | 33875569 | |
| Pubmed | 1.29e-07 | 8 | 47 | 3 | 9164858 | ||
| Pubmed | 1.93e-07 | 9 | 47 | 3 | 8562707 | ||
| Pubmed | 1.93e-07 | 9 | 47 | 3 | 15081423 | ||
| Pubmed | 1.93e-07 | 9 | 47 | 3 | 12101409 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FZD1 FOXO3 COL4A5 KMT2D SBF1 FHIP1B WNK1 ZNF341 ANXA11 ZNF516 COL1A1 | 1.93e-07 | 1105 | 47 | 11 | 35748872 |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 2.60e-07 | 101 | 47 | 5 | 20551380 | |
| Pubmed | 2.76e-07 | 10 | 47 | 3 | 9136074 | ||
| Pubmed | 2.76e-07 | 10 | 47 | 3 | 19304887 | ||
| Pubmed | Development of migrating tendon-bone attachments involves replacement of progenitor populations. | 2.76e-07 | 10 | 47 | 3 | 30504126 | |
| Pubmed | 3.79e-07 | 11 | 47 | 3 | 14998921 | ||
| Pubmed | 3.79e-07 | 11 | 47 | 3 | 9664687 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 3.79e-07 | 11 | 47 | 3 | 7500359 | |
| Pubmed | 3.79e-07 | 11 | 47 | 3 | 2745554 | ||
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 3.79e-07 | 11 | 47 | 3 | 9731539 | |
| Interaction | LAIR2 interactions | COL2A1 COL4A1 COL4A2 COL5A1 COLEC12 COL12A1 COL17A1 YAP1 COL1A1 | 1.13e-15 | 49 | 45 | 9 | int:LAIR2 |
| Interaction | MMP9 interactions | 1.89e-12 | 67 | 45 | 8 | int:MMP9 | |
| Interaction | MMP2 interactions | 1.64e-11 | 87 | 45 | 8 | int:MMP2 | |
| Interaction | COLGALT2 interactions | 1.34e-10 | 67 | 45 | 7 | int:COLGALT2 | |
| Interaction | COL8A2 interactions | 4.33e-10 | 42 | 45 | 6 | int:COL8A2 | |
| Interaction | C1QTNF1 interactions | 8.79e-10 | 47 | 45 | 6 | int:C1QTNF1 | |
| Interaction | PLOD1 interactions | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL12A1 COL16A1 COL1A1 LRRC47 | 1.40e-08 | 292 | 45 | 9 | int:PLOD1 |
| Interaction | C1QTNF2 interactions | 2.60e-07 | 62 | 45 | 5 | int:C1QTNF2 | |
| Interaction | TGFBI interactions | 2.65e-07 | 25 | 45 | 4 | int:TGFBI | |
| Interaction | THBS1 interactions | 3.70e-07 | 127 | 45 | 6 | int:THBS1 | |
| Interaction | COL11A1 interactions | 4.94e-07 | 29 | 45 | 4 | int:COL11A1 | |
| Interaction | MAG interactions | 4.94e-07 | 29 | 45 | 4 | int:MAG | |
| Interaction | BGN interactions | 5.70e-07 | 30 | 45 | 4 | int:BGN | |
| Interaction | PDGFA interactions | 7.45e-07 | 32 | 45 | 4 | int:PDGFA | |
| Interaction | COL1A2 interactions | 8.25e-07 | 78 | 45 | 5 | int:COL1A2 | |
| Interaction | DCN interactions | 2.51e-06 | 43 | 45 | 4 | int:DCN | |
| Interaction | CD93 interactions | 3.02e-06 | 45 | 45 | 4 | int:CD93 | |
| Interaction | SP7 interactions | 4.61e-06 | 304 | 45 | 7 | int:SP7 | |
| Interaction | HABP2 interactions | 8.29e-06 | 18 | 45 | 3 | int:HABP2 | |
| Interaction | COL16A1 interactions | 8.29e-06 | 18 | 45 | 3 | int:COL16A1 | |
| Interaction | OSM interactions | 1.15e-05 | 20 | 45 | 3 | int:OSM | |
| Interaction | COL2A1 interactions | 1.25e-05 | 64 | 45 | 4 | int:COL2A1 | |
| Interaction | TGM2 interactions | 1.31e-05 | 235 | 45 | 6 | int:TGM2 | |
| Interaction | SPARC interactions | 1.33e-05 | 65 | 45 | 4 | int:SPARC | |
| Interaction | FBLN2 interactions | 1.41e-05 | 66 | 45 | 4 | int:FBLN2 | |
| Interaction | SMAD1 interactions | 1.59e-05 | 243 | 45 | 6 | int:SMAD1 | |
| Interaction | NUP35 interactions | 3.95e-05 | 424 | 45 | 7 | int:NUP35 | |
| Interaction | PDGFB interactions | 4.41e-05 | 88 | 45 | 4 | int:PDGFB | |
| Interaction | PRELP interactions | 4.93e-05 | 32 | 45 | 3 | int:PRELP | |
| Interaction | P4HA1 interactions | 4.99e-05 | 298 | 45 | 6 | int:P4HA1 | |
| Interaction | ALG13 interactions | 5.32e-05 | 183 | 45 | 5 | int:ALG13 | |
| Interaction | PLOD3 interactions | 5.32e-05 | 183 | 45 | 5 | int:PLOD3 | |
| Interaction | FOXO3B interactions | 7.27e-05 | 6 | 45 | 2 | int:FOXO3B | |
| Interaction | C1QTNF9 interactions | 7.67e-05 | 37 | 45 | 3 | int:C1QTNF9 | |
| Interaction | C1QC interactions | 1.12e-04 | 42 | 45 | 3 | int:C1QC | |
| Interaction | MATN2 interactions | 1.17e-04 | 113 | 45 | 4 | int:MATN2 | |
| Interaction | BMP3 interactions | 1.35e-04 | 8 | 45 | 2 | int:BMP3 | |
| Interaction | COL4A1 interactions | 1.68e-04 | 48 | 45 | 3 | int:COL4A1 | |
| Interaction | ADAMTS5 interactions | 1.74e-04 | 9 | 45 | 2 | int:ADAMTS5 | |
| Interaction | TK1 interactions | 2.02e-04 | 243 | 45 | 5 | int:TK1 | |
| Interaction | COL5A3 interactions | 2.17e-04 | 10 | 45 | 2 | int:COL5A3 | |
| Interaction | SAA1 interactions | 2.38e-04 | 54 | 45 | 3 | int:SAA1 | |
| Interaction | SERPINE2 interactions | 2.65e-04 | 56 | 45 | 3 | int:SERPINE2 | |
| Interaction | TOP3B interactions | FZD1 FOXO3 COL4A5 KMT2D SBF1 FHIP1B WNK1 ZNF341 ANXA11 ZNF516 COL1A1 | 3.01e-04 | 1470 | 45 | 11 | int:TOP3B |
| Interaction | TIMP2 interactions | 3.69e-04 | 277 | 45 | 5 | int:TIMP2 | |
| Interaction | COL9A1 interactions | 3.74e-04 | 13 | 45 | 2 | int:COL9A1 | |
| Interaction | COL5A1 interactions | 4.12e-04 | 65 | 45 | 3 | int:COL5A1 | |
| Interaction | FN1 interactions | 5.14e-04 | 848 | 45 | 8 | int:FN1 | |
| Interaction | FGF7 interactions | 5.74e-04 | 16 | 45 | 2 | int:FGF7 | |
| Interaction | TLX1 interactions | 6.20e-04 | 175 | 45 | 4 | int:TLX1 | |
| Interaction | COL4A2 interactions | 6.28e-04 | 75 | 45 | 3 | int:COL4A2 | |
| Interaction | TEAD1 interactions | 6.33e-04 | 176 | 45 | 4 | int:TEAD1 | |
| Interaction | FOXO6 interactions | 6.49e-04 | 17 | 45 | 2 | int:FOXO6 | |
| Interaction | NFE2 interactions | 8.74e-04 | 84 | 45 | 3 | int:NFE2 | |
| Interaction | NID2 interactions | 9.35e-04 | 86 | 45 | 3 | int:NID2 | |
| Cytoband | 12p13.2 | 1.39e-07 | 45 | 47 | 4 | 12p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | 1.63e-06 | 353 | 47 | 6 | chr12p13 | |
| Cytoband | 13q34 | 1.42e-03 | 54 | 47 | 2 | 13q34 | |
| GeneFamily | Collagens | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.23e-23 | 46 | 35 | 12 | 490 |
| GeneFamily | Proline rich proteins | 1.76e-10 | 6 | 35 | 4 | 972 | |
| Coexpression | NABA_COLLAGENS | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.94e-24 | 43 | 45 | 12 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 2.67e-24 | 44 | 45 | 12 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 2.38e-14 | 270 | 45 | 12 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 2.96e-14 | 275 | 45 | 12 | M5884 |
| Coexpression | NABA_MATRISOME | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COLEC12 COL5A3 ANGPTL6 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 LGALS3 ANXA11 COL1A1 | 4.61e-12 | 1008 | 45 | 16 | MM17056 |
| Coexpression | NABA_MATRISOME | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COLEC12 COL5A3 ANGPTL6 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 LGALS3 ANXA11 COL1A1 | 6.02e-12 | 1026 | 45 | 16 | M5889 |
| Coexpression | GU_PDEF_TARGETS_UP | 3.30e-11 | 71 | 45 | 7 | M3955 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 4.45e-11 | 74 | 45 | 7 | M13547 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.37e-09 | 29 | 45 | 5 | MM17055 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.69e-09 | 200 | 45 | 8 | M5930 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 3.70e-09 | 35 | 45 | 5 | MM17054 | |
| Coexpression | KANG_AR_TARGETS_UP | 1.77e-08 | 17 | 45 | 4 | MM1297 | |
| Coexpression | KANG_AR_TARGETS_UP | 1.77e-08 | 17 | 45 | 4 | M2223 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 3.39e-07 | 162 | 45 | 6 | M45037 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | FZD1 COL4A1 COL4A2 COL5A1 COL5A3 COL11A1 COL12A1 COL16A1 YAP1 COL1A1 | 5.48e-07 | 767 | 45 | 10 | M39209 |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 5.81e-07 | 94 | 45 | 5 | M2580 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 6.13e-07 | 95 | 45 | 5 | MM1328 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 7.52e-07 | 99 | 45 | 5 | M39152 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 7.73e-07 | 11 | 45 | 3 | M47997 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 1.17e-06 | 46 | 45 | 4 | MM544 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 1.28e-06 | 47 | 45 | 4 | M1399 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN | 1.40e-06 | 48 | 45 | 4 | M1246 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 2.07e-06 | 505 | 45 | 8 | M39167 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 2.17e-06 | 352 | 45 | 7 | M17471 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 2.48e-06 | 126 | 45 | 5 | M39132 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 3.16e-06 | 17 | 45 | 3 | M47995 | |
| Coexpression | TRAVAGLINI_LUNG_MYOFIBROBLAST_CELL | 4.75e-06 | 65 | 45 | 4 | M41673 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 4.75e-06 | 65 | 45 | 4 | M39309 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 6.04e-06 | 69 | 45 | 4 | M10165 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 6.30e-06 | 268 | 45 | 6 | M45796 | |
| Coexpression | DESCARTES_MAIN_FETAL_STROMAL_CELLS | 7.12e-06 | 22 | 45 | 3 | M40074 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 8.18e-06 | 23 | 45 | 3 | M48001 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 8.74e-06 | 163 | 45 | 5 | M2769 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 1.26e-05 | 83 | 45 | 4 | M2448 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 1.34e-05 | 27 | 45 | 3 | M47994 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 1.61e-05 | 316 | 45 | 6 | M2293 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.62e-05 | 479 | 45 | 7 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.71e-05 | 483 | 45 | 7 | MM1082 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 1.82e-05 | 323 | 45 | 6 | MM1066 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 1.84e-05 | 681 | 45 | 8 | M39175 | |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN | 1.98e-05 | 93 | 45 | 4 | M4752 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 2.03e-05 | 194 | 45 | 5 | M39122 | |
| Coexpression | TRAVAGLINI_LUNG_SEROUS_CELL | 2.24e-05 | 96 | 45 | 4 | M41657 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL | 2.34e-05 | 97 | 45 | 4 | M45794 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 2.49e-05 | 33 | 45 | 3 | M9167 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS_TUMOR_CELL_DERIVED | 2.87e-05 | 5 | 45 | 2 | M47996 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 3.03e-05 | 211 | 45 | 5 | M12225 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 3.97e-05 | 111 | 45 | 4 | M45685 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 4.47e-05 | 40 | 45 | 3 | M5887 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 4.88e-05 | 117 | 45 | 4 | M39300 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 5.38e-05 | 120 | 45 | 4 | M42505 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 5.96e-05 | 44 | 45 | 3 | M18274 | |
| Coexpression | BENPORATH_EED_TARGETS | COL2A1 FZD1 HOXA4 COL4A5 COLEC12 COL12A1 LRCH2 LGALS3 LRRC47 | 6.61e-05 | 1059 | 45 | 9 | M7617 |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 7.27e-05 | 47 | 45 | 3 | M7585 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 9.01e-05 | 137 | 45 | 4 | M40313 | |
| Coexpression | SENESE_HDAC1_TARGETS_DN | 9.25e-05 | 267 | 45 | 5 | M6100 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 1.01e-04 | 141 | 45 | 4 | M10381 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | COL4A1 COL4A2 COL4A5 COL5A1 COLEC12 COL11A1 COL11A2 COL12A1 COL1A1 | 1.13e-04 | 1136 | 45 | 9 | M2247 |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 1.15e-04 | 146 | 45 | 4 | MM973 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 1.24e-04 | 457 | 45 | 6 | M1613 | |
| Coexpression | CORRE_MULTIPLE_MYELOMA_DN | 1.44e-04 | 59 | 45 | 3 | M990 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 1.45e-04 | 470 | 45 | 6 | MM1053 | |
| Coexpression | LEE_LIVER_CANCER_DENA_UP | 1.51e-04 | 60 | 45 | 3 | M16524 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 1.67e-04 | 62 | 45 | 3 | M16774 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | COL4A1 COL4A2 COL4A5 COL5A1 COLEC12 COL11A1 COL11A2 COL12A1 COL1A1 | 1.69e-04 | 1198 | 45 | 9 | MM1062 |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 1.83e-04 | 64 | 45 | 3 | M2572 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS_TUMOR_CELL_DERIVED | 1.88e-04 | 12 | 45 | 2 | M47998 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 2.09e-04 | 503 | 45 | 6 | M2226 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 2.19e-04 | 68 | 45 | 3 | M1373 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE | 2.19e-04 | 68 | 45 | 3 | M45669 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 2.41e-04 | 177 | 45 | 4 | M39245 | |
| Coexpression | JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_DN | 2.59e-04 | 14 | 45 | 2 | MM453 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 2.60e-04 | 72 | 45 | 3 | M9908 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 2.60e-04 | 72 | 45 | 3 | MM1131 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 2.73e-04 | 337 | 45 | 5 | M13206 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 2.85e-04 | 185 | 45 | 4 | M42503 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 2.93e-04 | 75 | 45 | 3 | MM1084 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 2.98e-04 | 15 | 45 | 2 | MM402 | |
| Coexpression | BRUECKNER_TARGETS_OF_MIRLET7A3_DN | 3.05e-04 | 76 | 45 | 3 | M11825 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 3.09e-04 | 541 | 45 | 6 | MM1061 | |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN | 3.16e-04 | 77 | 45 | 3 | M17937 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 3.29e-04 | 192 | 45 | 4 | M42501 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | 3.29e-04 | 192 | 45 | 4 | M2776 | |
| Coexpression | DEMAGALHAES_AGING_DN | 3.41e-04 | 16 | 45 | 2 | M2145 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 3.41e-04 | 79 | 45 | 3 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 3.54e-04 | 80 | 45 | 3 | MM1285 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 3.67e-04 | 81 | 45 | 3 | M39253 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 3.76e-04 | 199 | 45 | 4 | M6651 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | 3.82e-04 | 1054 | 45 | 8 | M45798 | |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | 3.82e-04 | 563 | 45 | 6 | M15103 | |
| Coexpression | GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN | 3.84e-04 | 200 | 45 | 4 | M4845 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_UP | 3.84e-04 | 200 | 45 | 4 | M4024 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 4.14e-04 | 369 | 45 | 5 | MM16610 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 4.33e-04 | 18 | 45 | 2 | M47984 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 4.38e-04 | 86 | 45 | 3 | M39247 | |
| Coexpression | GAO_ESOPHAGUS_25W_C4_FGFR1HIGH_EPITHELIAL_CELLS | 4.45e-04 | 208 | 45 | 4 | M39139 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | 4.61e-04 | 210 | 45 | 4 | MM751 | |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP | 4.84e-04 | 89 | 45 | 3 | M2761 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 5.02e-04 | 385 | 45 | 5 | M39264 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_MESENCHYMAL | 5.13e-04 | 216 | 45 | 4 | M2122 | |
| CoexpressionAtlas | BM Top 100 - endometrium | 2.76e-07 | 66 | 45 | 5 | BM Top 100 - endometrium | |
| CoexpressionAtlas | salivary gland | 8.73e-07 | 83 | 45 | 5 | salivary gland | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | COL2A1 COL4A1 COL4A2 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 LRCH2 SEZ6L2 COL1A1 | 3.43e-06 | 951 | 45 | 11 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.56e-06 | 197 | 45 | 6 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#5 | 4.58e-06 | 116 | 45 | 5 | ratio_EB_vs_SC_500_K5 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL2A1 FZD1 HOXA4 COL4A1 COL4A2 COL5A1 COLEC12 COL5A3 COL11A1 COL12A1 COL1A1 | 1.30e-05 | 1094 | 45 | 11 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 1.63e-05 | 72 | 45 | 4 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 1.82e-05 | 74 | 45 | 4 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 7.27e-05 | 336 | 45 | 6 | ratio_EB_vs_SC_1000_K1 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COLEC12 COL11A1 FHIP1B ANXA11 ZNF516 | 1.20e-04 | 1153 | 45 | 10 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.23e-04 | 230 | 45 | 5 | gudmap_developingGonad_P2_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.33e-04 | 234 | 45 | 5 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 1.74e-04 | 761 | 45 | 8 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.76e-04 | 814 | 45 | 8 | JC_fibro_2500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.55e-04 | 159 | 45 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k3 | |
| CoexpressionAtlas | BM Top 100 - cervix | 3.71e-04 | 66 | 45 | 3 | BM Top 100 - cervix | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.17e-04 | 464 | 45 | 6 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 4.41e-04 | 70 | 45 | 3 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 6.05e-04 | 498 | 45 | 6 | PCBC_ratio_EB_vs_SC_500 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 6.05e-04 | 78 | 45 | 3 | PCBC_ratio_DE_from-OSKM_vs_DE_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSKM - NLT_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 6.25e-04 | 501 | 45 | 6 | PCBC_ratio_MESO-30_from-OSKM - NLT_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-30 fibroblast_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 6.25e-04 | 501 | 45 | 6 | PCBC_ratio_MESO-30 fibroblast_vs_MESO-30 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-method_plasmid_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | 6.25e-04 | 501 | 45 | 6 | PCBC_ratio_MESO-30_from-plasmid_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | placenta | 8.30e-04 | 349 | 45 | 5 | placenta | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K0 | 8.61e-04 | 88 | 45 | 3 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K0 | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSK-L-l-p53KD_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 8.89e-04 | 89 | 45 | 3 | PCBC_ratio_MESO-30_from-OSK-L-l-p53KD_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-method_episomal_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | 8.89e-04 | 89 | 45 | 3 | PCBC_ratio_MESO-30_from-episomal_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 8.89e-04 | 89 | 45 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k2_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 9.39e-04 | 206 | 45 | 4 | JC_fibro_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_500 | 9.79e-04 | 92 | 45 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k1 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | 1.01e-03 | 990 | 45 | 8 | JC_fibro_1000 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | 1.03e-03 | 994 | 45 | 8 | PCBC_ratio_EB_vs_SC_1000 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FZD1 COL4A1 COL4A2 COL4A5 COL5A1 COLEC12 COL11A1 COL12A1 COL16A1 COL1A1 | 5.74e-15 | 197 | 45 | 10 | 86145bc1e585b4ae136e755cafd6579da2abfa65 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL16A1 COL1A1 | 6.05e-15 | 198 | 45 | 10 | b086af292a508a156266c2d899ba1caf820bf61c |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL11A1 COL11A2 COL16A1 COL1A1 | 3.47e-13 | 195 | 45 | 9 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FZD1 COL4A1 COL4A2 COL5A1 COLEC12 COL11A1 COL12A1 COL16A1 COL1A1 | 3.63e-13 | 196 | 45 | 9 | f47e551ba484687ba6ce8c29a085106131364042 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL1A1 | 3.98e-13 | 198 | 45 | 9 | 1b90d632e59c3c47b936e829cceeb0334f05f34f |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-11 | 194 | 45 | 8 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-11 | 194 | 45 | 8 | ee6b5fb4e993a4c0dc556091b8fefd56bdc70d8f | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-11 | 195 | 45 | 8 | 841fde528ecb293e07b5e00e499d1e9f0b0dce14 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-11 | 195 | 45 | 8 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-11 | 195 | 45 | 8 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-11 | 195 | 45 | 8 | 223f5f07dc28fa13a09bb589884c58043c7928c7 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.20e-11 | 197 | 45 | 8 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL5A1 COLEC12 COL11A1 COL11A2 COL12A1 COL16A1 COL1A1 | 2.29e-11 | 198 | 45 | 8 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.38e-11 | 199 | 45 | 8 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-11 | 199 | 45 | 8 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.38e-11 | 199 | 45 | 8 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.48e-11 | 200 | 45 | 8 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-10 | 155 | 45 | 7 | 82e602f31981c6b48abff2a04b2ab5d26d4462a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-10 | 155 | 45 | 7 | 979c1d53b435a82c57d16707eed8ba7346326866 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.79e-10 | 162 | 45 | 7 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.05e-10 | 181 | 45 | 7 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.05e-10 | 181 | 45 | 7 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.32e-10 | 186 | 45 | 7 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.89e-10 | 188 | 45 | 7 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.81e-10 | 191 | 45 | 7 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.81e-10 | 191 | 45 | 7 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 8.81e-10 | 191 | 45 | 7 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.81e-10 | 191 | 45 | 7 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-10 | 193 | 45 | 7 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-10 | 193 | 45 | 7 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.82e-10 | 194 | 45 | 7 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-09 | 195 | 45 | 7 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-09 | 195 | 45 | 7 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 1.05e-09 | 196 | 45 | 7 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.05e-09 | 196 | 45 | 7 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-09 | 197 | 45 | 7 | 036c4c9b3ae80e2dc21c24a84504d3da0541f945 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-09 | 197 | 45 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-09 | 197 | 45 | 7 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-09 | 197 | 45 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-09 | 198 | 45 | 7 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.13e-09 | 198 | 45 | 7 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.13e-09 | 198 | 45 | 7 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.13e-09 | 198 | 45 | 7 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-09 | 198 | 45 | 7 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.13e-09 | 198 | 45 | 7 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-09 | 198 | 45 | 7 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.13e-09 | 198 | 45 | 7 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.17e-09 | 199 | 45 | 7 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.17e-09 | 199 | 45 | 7 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 1.17e-09 | 199 | 45 | 7 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.17e-09 | 199 | 45 | 7 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.17e-09 | 199 | 45 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.21e-09 | 200 | 45 | 7 | 07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.21e-09 | 200 | 45 | 7 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.21e-09 | 200 | 45 | 7 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.21e-09 | 200 | 45 | 7 | ff0b2675c68e9fc1fa16b3276431f199f3642eac | |
| ToppCell | Lung_Parenchyma|World / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.26e-09 | 201 | 45 | 7 | 91ec5eebe93a3c7b1a33c27e5da949b123b676a8 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 2.21e-08 | 174 | 45 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-08 | 176 | 45 | 6 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-08 | 176 | 45 | 6 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.53e-08 | 178 | 45 | 6 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.70e-08 | 180 | 45 | 6 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-08 | 180 | 45 | 6 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.70e-08 | 180 | 45 | 6 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 2.79e-08 | 181 | 45 | 6 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.98e-08 | 183 | 45 | 6 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.98e-08 | 183 | 45 | 6 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.98e-08 | 183 | 45 | 6 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 3.08e-08 | 184 | 45 | 6 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-08 | 185 | 45 | 6 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-08 | 185 | 45 | 6 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-08 | 186 | 45 | 6 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-08 | 188 | 45 | 6 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.50e-08 | 188 | 45 | 6 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.50e-08 | 188 | 45 | 6 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 3.50e-08 | 188 | 45 | 6 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.61e-08 | 189 | 45 | 6 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 3.61e-08 | 189 | 45 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.61e-08 | 189 | 45 | 6 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.61e-08 | 189 | 45 | 6 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.72e-08 | 190 | 45 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-08 | 190 | 45 | 6 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-08 | 190 | 45 | 6 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-08 | 190 | 45 | 6 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.72e-08 | 190 | 45 | 6 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.84e-08 | 191 | 45 | 6 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.84e-08 | 191 | 45 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-08 | 191 | 45 | 6 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-08 | 192 | 45 | 6 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-08 | 192 | 45 | 6 | b35f0e422070ba9c7c1d9ff3eace4edc10286cde | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-08 | 192 | 45 | 6 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | (3)_Chondrocytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.96e-08 | 192 | 45 | 6 | 5d2b4830d025d3dbdf5623ce1c28d1036e1984a8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-08 | 192 | 45 | 6 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-08 | 192 | 45 | 6 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.08e-08 | 193 | 45 | 6 | dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68 | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-08 | 193 | 45 | 6 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.08e-08 | 193 | 45 | 6 | 2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-08 | 193 | 45 | 6 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.08e-08 | 193 | 45 | 6 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-08 | 194 | 45 | 6 | b294056f9bdc243263cf36dce7b62564144b9de1 | |
| Computational | Adhesion molecules. | 1.16e-07 | 141 | 31 | 7 | MODULE_122 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.19e-05 | 50 | 31 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | ECM and collagens. | 3.74e-05 | 225 | 31 | 6 | MODULE_47 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.88e-04 | 50 | 31 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.88e-04 | 50 | 31 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | Bone remodeling. | 4.88e-04 | 54 | 31 | 3 | MODULE_234 | |
| Drug | GK-101 | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 7.60e-20 | 36 | 45 | 10 | CID000161853 |
| Drug | Madecassol | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.20e-18 | 46 | 45 | 10 | CID000108062 |
| Drug | d-indobufen | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 3.01e-18 | 50 | 45 | 10 | CID000044562 |
| Drug | ridogrel | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 4.62e-18 | 52 | 45 | 10 | CID005362391 |
| Drug | NSC49633 | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 5.69e-18 | 53 | 45 | 10 | CID000023340 |
| Drug | DMSe | COL2A1 COL4A1 TPRX1 COL4A5 COL5A1 COL5A3 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 2.12e-17 | 132 | 45 | 12 | CID000020796 |
| Drug | AC1LAKND | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 3.10e-17 | 62 | 45 | 10 | CID000470146 |
| Drug | BAPN | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.31e-16 | 71 | 45 | 10 | CID000001647 |
| Drug | malotilate | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.31e-16 | 71 | 45 | 10 | CID000004006 |
| Drug | AC1NMZ1B | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 2.35e-16 | 75 | 45 | 10 | CID005034185 |
| Drug | strontium ranelate | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 3.09e-16 | 77 | 45 | 10 | CID006918182 |
| Drug | halofuginone lactate | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 8.73e-16 | 85 | 45 | 10 | CID000062891 |
| Drug | 4-hydroxyproline | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.78e-15 | 91 | 45 | 10 | CID000000825 |
| Drug | ticlopidine | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 6.42e-15 | 103 | 45 | 10 | CID000005472 |
| Drug | hydroxylysine | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.15e-14 | 109 | 45 | 10 | CID000001029 |
| Drug | AC1L1C2F | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.26e-14 | 110 | 45 | 10 | CID000001711 |
| Drug | PPACK | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.67e-14 | 113 | 45 | 10 | CID003036757 |
| Drug | AC1L9732 | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.82e-14 | 114 | 45 | 10 | CID000439300 |
| Drug | Tranilast sodium | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.99e-14 | 115 | 45 | 10 | CID000005527 |
| Drug | Selara | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 4.68e-14 | 125 | 45 | 10 | CID000150310 |
| Drug | pirfenidone | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.28e-13 | 138 | 45 | 10 | CID000040632 |
| Drug | DL-penicillamine | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.38e-13 | 139 | 45 | 10 | CID000004727 |
| Drug | PCR 4099 | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.38e-13 | 139 | 45 | 10 | CID000002806 |
| Drug | candesartan cilexetil | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 2.11e-13 | 145 | 45 | 10 | CID000002540 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 6.47e-13 | 162 | 45 | 10 | CID000072363 |
| Drug | AC1Q6PCP | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 PRB1 COL1A1 | 6.60e-13 | 230 | 45 | 11 | CID000005267 |
| Drug | khellin | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.11e-12 | 171 | 45 | 10 | CID000003828 |
| Drug | AC1L1DD6 | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.76e-12 | 179 | 45 | 10 | CID000002299 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 3.03e-12 | 189 | 45 | 10 | CID000001413 |
| Drug | foscarnet | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 3.20e-12 | 190 | 45 | 10 | CID000003414 |
| Drug | prostacyclin sodium salt | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 4.85e-11 | 250 | 45 | 10 | CID000000159 |
| Drug | hyaluronan | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 7.97e-11 | 263 | 45 | 10 | CID000024759 |
| Drug | silibinin | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.75e-10 | 285 | 45 | 10 | CID000005213 |
| Drug | BPAT-143 | 1.99e-10 | 6 | 45 | 4 | CID000146249 | |
| Drug | NC-4 | 2.81e-10 | 44 | 45 | 6 | CID006420119 | |
| Drug | 351A | 3.64e-10 | 20 | 45 | 5 | CID000122144 | |
| Drug | (2s,5s)-5-Carboxymethylproline | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 4.49e-10 | 314 | 45 | 10 | CID000447989 |
| Drug | AC1L18QD | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 6.27e-10 | 325 | 45 | 10 | CID000000213 |
| Drug | Y-27632 | COL2A1 COL4A1 FOXO3 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 7.67e-10 | 444 | 45 | 11 | CID000005711 |
| Drug | AC1L1KMJ | COL2A1 COL4A1 COL4A5 COL5A1 COLEC12 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.59e-09 | 476 | 45 | 11 | CID000030956 |
| Drug | losartan | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 2.69e-09 | 378 | 45 | 10 | CID000003961 |
| Drug | colchine | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 3.05e-09 | 383 | 45 | 10 | CID000002833 |
| Drug | pyrachlostrobin | COL4A1 COL4A5 COL5A1 COLEC12 COL5A3 COL11A1 COL12A1 COL16A1 WNK1 YAP1 LGALS3 ZNF516 COL1A1 | 3.43e-09 | 811 | 45 | 13 | ctd:C513428 |
| Drug | isodesmosine | 5.46e-09 | 33 | 45 | 5 | CID000013811 | |
| Drug | chondroitin sulfate | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 6.27e-09 | 413 | 45 | 10 | CID000024766 |
| Drug | calcium phosphate | 1.64e-08 | 149 | 45 | 7 | CID000024441 | |
| Drug | PD123177 | 2.18e-08 | 43 | 45 | 5 | CID000114899 | |
| Drug | desmosine | 6.41e-08 | 53 | 45 | 5 | CID000025435 | |
| Drug | aspirin | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 1.16e-07 | 563 | 45 | 10 | CID000002244 |
| Drug | L-3,4-dehydroproline | 3.26e-07 | 73 | 45 | 5 | CID000094284 | |
| Drug | LS-63783 | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 ANXA11 COL1A1 | 3.37e-07 | 804 | 45 | 11 | CID000000231 |
| Drug | rhamnose | 4.30e-07 | 356 | 45 | 8 | CID000000840 | |
| Drug | LMWH | COL2A1 COL4A1 COL4A5 COL5A1 COL11A1 COL11A2 COL12A1 COL16A1 COL17A1 COL1A1 | 5.21e-07 | 663 | 45 | 10 | CID000000772 |
| Drug | Sirius red | 6.66e-07 | 35 | 45 | 4 | CID005486818 | |
| Drug | AC1MRIIV | 1.04e-06 | 39 | 45 | 4 | CID003518584 | |
| Drug | pyridinoline | 1.49e-06 | 99 | 45 | 5 | CID000105068 | |
| Drug | 1zd2 | 1.87e-06 | 45 | 45 | 4 | CID004149241 | |
| Drug | F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A | 2.25e-06 | 195 | 45 | 6 | 6424_DN | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.46e-06 | 198 | 45 | 6 | 3761_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A | 2.54e-06 | 199 | 45 | 6 | 5575_DN | |
| Drug | 2-(4-((4-(6-methoxy-3-pyridinyl)-5-(4-(trifluoromethoxy)phenyl)-2-thiazolyl)methoxy)-2-methylphenoxy)acetic acid | 3.36e-06 | 52 | 45 | 4 | ctd:C573693 | |
| Drug | dermatan sulfate | 4.52e-06 | 220 | 45 | 6 | CID000032756 | |
| Drug | 1h00 | 4.54e-06 | 56 | 45 | 4 | CID000445950 | |
| Drug | trapidil | 4.87e-06 | 57 | 45 | 4 | CID000005531 | |
| Drug | AC1Q641C | 6.83e-06 | 62 | 45 | 4 | CID000005005 | |
| Drug | mitomycin C | 7.62e-06 | 241 | 45 | 6 | CID000005746 | |
| Drug | 4-aminoazobenzene | 8.77e-06 | 66 | 45 | 4 | CID000006051 | |
| Drug | maltos | 1.12e-05 | 393 | 45 | 7 | CID000000294 | |
| Drug | Mifepristone | 1.12e-05 | 553 | 45 | 8 | ctd:D015735 | |
| Drug | A0395 | 1.46e-05 | 75 | 45 | 4 | CID009906466 | |
| Drug | YIGSR | 1.80e-05 | 79 | 45 | 4 | CID000123977 | |
| Drug | homocystine | 2.08e-05 | 82 | 45 | 4 | CID000010010 | |
| Drug | Collagenase | 2.29e-05 | 4 | 45 | 2 | DB00048 | |
| Drug | diacetylrhein | 2.29e-05 | 4 | 45 | 2 | ctd:C025292 | |
| Drug | AC1L9HPX | 3.28e-05 | 92 | 45 | 4 | CID000445279 | |
| Drug | D3273 | 3.57e-05 | 94 | 45 | 4 | CID005464587 | |
| Drug | 17-DMAG; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.67e-05 | 191 | 45 | 5 | 4437_DN | |
| Drug | STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A | 3.86e-05 | 193 | 45 | 5 | 6427_DN | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; PC3; HT_HG-U133A | 4.15e-05 | 196 | 45 | 5 | 5084_UP | |
| Drug | DNA-PK Inhibitor III; Down 200; 1uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 45 | 5 | 7513_DN | |
| Drug | Gabazine [105538-73-6]; Down 200; 10.8uM; PC3; HT_HG-U133A | 4.15e-05 | 196 | 45 | 5 | 4236_DN | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 4.25e-05 | 197 | 45 | 5 | 5276_UP | |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.25e-05 | 197 | 45 | 5 | 7052_UP | |
| Drug | nitrendipine; Up 200; 10uM; MCF7; HG-U133A | 4.36e-05 | 198 | 45 | 5 | 336_UP | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 4.36e-05 | 198 | 45 | 5 | 2644_UP | |
| Drug | 0225151-0000 [351320-15-5]; Down 200; 10uM; PC3; HT_HG-U133A | 4.36e-05 | 198 | 45 | 5 | 6426_DN | |
| Drug | Sialic acids | 4.41e-05 | 329 | 45 | 6 | CID000349960 | |
| Drug | Tropine [120-29-6]; Up 200; 28.4uM; MCF7; HT_HG-U133A | 4.46e-05 | 199 | 45 | 5 | 3569_UP | |
| Drug | Diphosphonates | 5.70e-05 | 6 | 45 | 2 | ctd:D004164 | |
| Drug | AG-H-50319 | 5.70e-05 | 6 | 45 | 2 | CID011819195 | |
| Drug | 17-isoprogesterone | COL2A1 COL4A5 COL5A1 COL11A1 COL11A2 COL16A1 PRB1 LGALS3 ANXA11 COL1A1 | 7.59e-05 | 1170 | 45 | 10 | CID000004920 |
| Drug | N-methylmesoporphyrin | 7.85e-05 | 42 | 45 | 3 | CID000444708 | |
| Drug | 3,4,5-trihydroxy-N-(4-(thiazol-2-ylsulfamoyl)-phenyl)-benzamide | 1.06e-04 | 8 | 45 | 2 | ctd:C000594958 | |
| Drug | ciglitazone | 1.10e-04 | 241 | 45 | 5 | ctd:C039671 | |
| Drug | 2,3-pentanedione | 1.22e-04 | 129 | 45 | 4 | ctd:C013186 | |
| Drug | aldosterone | 1.24e-04 | 397 | 45 | 6 | CID000005839 | |
| Drug | Simvastatin | 1.33e-04 | 581 | 45 | 7 | ctd:D019821 | |
| Drug | ptaquiloside | 1.38e-04 | 133 | 45 | 4 | ctd:C043680 | |
| Drug | 4,4'-hexafluorisopropylidene diphenol | 1.77e-04 | 142 | 45 | 4 | ctd:C583074 | |
| Drug | fluoride | 2.15e-04 | 278 | 45 | 5 | CID000014917 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.59e-08 | 53 | 44 | 5 | C4707243 | |
| Disease | Stickler syndrome | 3.09e-08 | 5 | 44 | 3 | cv:C0265253 | |
| Disease | dermoid cyst of ovary (implicated_via_orthology) | 2.17e-06 | 2 | 44 | 2 | DOID:5117 (implicated_via_orthology) | |
| Disease | Fibrochondrogenesis | 2.17e-06 | 2 | 44 | 2 | C0265282 | |
| Disease | Developmental Porencephaly | 2.17e-06 | 2 | 44 | 2 | C4082301 | |
| Disease | Post-traumatic Porencephaly | 2.17e-06 | 2 | 44 | 2 | C3698507 | |
| Disease | Congenital porencephaly | 2.17e-06 | 2 | 44 | 2 | C0302892 | |
| Disease | Megaepiphyseal dwarfism | 2.17e-06 | 2 | 44 | 2 | C1855310 | |
| Disease | Porencephaly | 2.17e-06 | 2 | 44 | 2 | C4082173 | |
| Disease | Otospondylomegaepiphyseal dysplasia | 2.17e-06 | 2 | 44 | 2 | C4520892 | |
| Disease | PORENCEPHALY, FAMILIAL | 2.17e-06 | 2 | 44 | 2 | C1867983 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 2.17e-06 | 2 | 44 | 2 | C3281105 | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 2.17e-06 | 2 | 44 | 2 | C4551998 | |
| Disease | Stickler syndrome (implicated_via_orthology) | 2.17e-06 | 2 | 44 | 2 | DOID:0080046 (implicated_via_orthology) | |
| Disease | Stickler syndrome, type 3 | 2.17e-06 | 2 | 44 | 2 | C1861481 | |
| Disease | Disproportionate short stature | 5.37e-06 | 77 | 44 | 4 | C0878659 | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 6.51e-06 | 3 | 44 | 2 | C4552122 | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 6.51e-06 | 3 | 44 | 2 | C0220679 | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 6.51e-06 | 3 | 44 | 2 | cv:C3281105 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 6.51e-06 | 3 | 44 | 2 | 614519 | |
| Disease | Cleft Palate | 6.58e-06 | 81 | 44 | 4 | C0008925 | |
| Disease | Nephrotic Syndrome | 8.82e-06 | 27 | 44 | 3 | C0027726 | |
| Disease | Stickler syndrome, type 1 | 2.17e-05 | 5 | 44 | 2 | C2020284 | |
| Disease | Cartilage Diseases | 3.25e-05 | 6 | 44 | 2 | C0007302 | |
| Disease | Chondromalacia | 3.25e-05 | 6 | 44 | 2 | C0085700 | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 4.54e-05 | 7 | 44 | 2 | C1846545 | |
| Disease | Bleeding tendency | 4.54e-05 | 7 | 44 | 2 | C1458140 | |
| Disease | Ehlers-Danlos syndrome | 6.05e-05 | 8 | 44 | 2 | cv:C0013720 | |
| Disease | Hereditary hearing loss and deafness | 6.69e-05 | 146 | 44 | 4 | cv:C0236038 | |
| Disease | Hematuria | 7.77e-05 | 9 | 44 | 2 | C0018965 | |
| Disease | Sensory hearing loss | 1.19e-04 | 11 | 44 | 2 | C1691779 | |
| Disease | keratoconus | 1.33e-04 | 66 | 44 | 3 | MONDO_0015486 | |
| Disease | Liver Cirrhosis, Experimental | 1.37e-04 | 774 | 44 | 7 | C0023893 | |
| Disease | collagen disease (implicated_via_orthology) | 1.42e-04 | 12 | 44 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | cleft palate (is_implicated_in) | 1.42e-04 | 12 | 44 | 2 | DOID:674 (is_implicated_in) | |
| Disease | osteoarthritis (implicated_via_orthology) | 2.25e-04 | 15 | 44 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | Blood Coagulation Disorders | 2.57e-04 | 16 | 44 | 2 | C0005779 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 2.57e-04 | 16 | 44 | 2 | C4551479 | |
| Disease | Spondyloepiphyseal Dysplasia | 2.57e-04 | 16 | 44 | 2 | C0038015 | |
| Disease | Schwartz-Jampel Syndrome | 2.57e-04 | 16 | 44 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 2.57e-04 | 16 | 44 | 2 | C0025237 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 2.57e-04 | 16 | 44 | 2 | C3541456 | |
| Disease | Disorder of eye | 2.81e-04 | 212 | 44 | 4 | C0015397 | |
| Disease | Van Buchem disease | 2.91e-04 | 17 | 44 | 2 | C0432272 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.66e-04 | 19 | 44 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Dyschondroplasias | 3.66e-04 | 19 | 44 | 2 | C0013366 | |
| Disease | Osteochondrodysplasias | 3.66e-04 | 19 | 44 | 2 | C0029422 | |
| Disease | waist-hip ratio | 4.05e-04 | 1226 | 44 | 8 | EFO_0004343 | |
| Disease | Multiple Epiphyseal Dysplasia | 4.06e-04 | 20 | 44 | 2 | C0026760 | |
| Disease | glomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement | 4.93e-04 | 22 | 44 | 2 | EFO_0005199, EFO_0005208, EFO_0007892 | |
| Disease | sex interaction measurement, bilirubin measurement | 4.93e-04 | 22 | 44 | 2 | EFO_0004570, EFO_0008343 | |
| Disease | Sensorineural Hearing Loss (disorder) | 5.39e-04 | 23 | 44 | 2 | C0018784 | |
| Disease | Early Pregnancy Loss | 5.82e-04 | 109 | 44 | 3 | C3830362 | |
| Disease | Miscarriage | 5.82e-04 | 109 | 44 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 5.82e-04 | 109 | 44 | 3 | C0000786 | |
| Disease | Abortion, Tubal | 5.82e-04 | 109 | 44 | 3 | C0000822 | |
| Disease | migraine disorder, pulse pressure measurement | 6.90e-04 | 26 | 44 | 2 | EFO_0005763, MONDO_0005277 | |
| Disease | Cerebral Hemorrhage | 8.01e-04 | 28 | 44 | 2 | C2937358 | |
| Disease | peak expiratory flow | 8.47e-04 | 498 | 44 | 5 | EFO_0009718 | |
| Disease | spontaneous coronary artery dissection | 9.83e-04 | 31 | 44 | 2 | EFO_0010820 | |
| Disease | Keloid | 1.25e-03 | 35 | 44 | 2 | C0022548 | |
| Disease | Focal glomerulosclerosis | 1.33e-03 | 36 | 44 | 2 | C0017668 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLNLQGPPGPPGPQG | 946 | Q9UMD9 | |
| PGQQPPGAYPGQPPV | 136 | P50995 | |
| DQGFQGQPGFPGPPG | 1151 | Q07092 | |
| GQQDGPGPPSPGQSP | 1306 | Q6F5E8 | |
| GGGNLPSAPPPANFP | 281 | P54259 | |
| GQPGPVGPQGYNGPP | 61 | P08572 | |
| PPGPAGAPGPQGFQG | 211 | P02458 | |
| PAGPPGAQGPPGLQG | 736 | P02458 | |
| PQGPPGEIGFPGQPG | 481 | P02462 | |
| NFGGSNAFGPPIPPP | 726 | Q9NTZ6 | |
| PPNGPLQPGRPSLGG | 41 | Q9ULW5 | |
| GPGHLPPPQLNGVPG | 626 | Q8N612 | |
| AQQLGLGPPFPGPPF | 251 | Q2Q1W2 | |
| PGQGLGPAEPPGLPQ | 116 | Q8N1G4 | |
| PGQAPPGAYPGQAPP | 46 | P17931 | |
| EPGPPGQQGNPGPQG | 686 | P12107 | |
| GQQGNPGPQGLPGPQ | 691 | P12107 | |
| QGPQGPVGFPGPKGP | 921 | P12107 | |
| NGPPGPPGLQGPVGA | 1146 | P12107 | |
| GLPGPQGPPGFQGLQ | 536 | Q5KU26 | |
| GPPGERGLPGPQGPN | 871 | P13942 | |
| RGLPGPQGPNGFPGP | 876 | P13942 | |
| PQGPNGFPGPKGPLG | 881 | P13942 | |
| QGGELGAPGNLQPPP | 321 | P0DV76 | |
| APPQANGGPPDPGFL | 1306 | O95248 | |
| TPGQPGPQRFDGPPG | 1066 | O94913 | |
| SPQGPNFNGPHGPGN | 1161 | O94913 | |
| GQGPGQGPGPGQQPP | 76 | Q9UP38 | |
| QPLPPPQPGAAGGSG | 216 | A0A2Z4LIS9 | |
| GPQGPPGPQGPNGLS | 2786 | Q99715 | |
| GNPGYPGPPGIQGLP | 171 | P29400 | |
| KGEPGQPGFGNPGPP | 1181 | P29400 | |
| QPGFGNPGPPGLPGL | 1186 | P29400 | |
| PGGAGGQQQVLPPPP | 186 | Q8NI99 | |
| NGPQGPTGFPGPKGP | 951 | P20908 | |
| QGPPGPTGPQGPIGQ | 1176 | P20908 | |
| PGGGPGYQQPPAPPT | 36 | Q00056 | |
| VGPPGEPGPPGQQGN | 631 | P25940 | |
| PPPQAQPQPSGTGGG | 91 | Q8IU81 | |
| PPQGKPQGPPQQGGH | 86 | P02810 | |
| QQGGHPPPPQGRPQG | 96 | P02810 | |
| PQGGRPQGPPQGQSP | 151 | P02810 | |
| PQGAPPQGGNKPQGP | 36 | P02812 | |
| FGQPFPNGPPWNPGS | 56 | Q5VUJ6 | |
| GGNQSQGPPPHPGKP | 106 | P10163 | |
| PQGGNQSQGTPPPPG | 146 | P10163 | |
| GGNQSQGPPPHPGKP | 211 | P10163 | |
| PAGGNPQQPQAPPAG | 271 | P10163 | |
| GPFNPGPFNQGPPGA | 516 | Q92945 | |
| GPFNQGPPGAPPHAG | 521 | Q92945 | |
| QPLPPPQPGAAGGSG | 131 | O43524 | |
| FQAPPGPPNPGLGQG | 616 | Q6UXD5 | |
| NPFQPNGLAPGPGFG | 381 | O95081 | |
| GPPGAPGPQGFQGPP | 191 | P02452 | |
| EGPPPQGGNQSQGPP | 121 | Q04118 | |
| PEGPPPQGGNQSQGP | 141 | Q04118 | |
| PQGGNQSQGPPPHPG | 146 | Q04118 | |
| PGKPEGPPPQGGNQS | 201 | Q04118 | |
| PQGPSPQGGNKPQGP | 36 | P04280 | |
| PPGKPQGPPQQGGNR | 236 | P04280 | |
| PAGQPQGPPRPPQGG | 371 | P04280 | |
| QPQGPPPAKGEGGAP | 981 | Q92618 | |
| PQSLGPPGRPNPGGN | 201 | Q9BYN7 | |
| FSGPNPGPIPGPNPG | 171 | Q8N7U7 | |
| SQPPQGQGPPSGPGQ | 21 | P46937 | |
| GGPAPQPLGQFQPVG | 2341 | Q9H4A3 | |
| GPQGPPGPQGHIGPQ | 706 | Q9C0J8 | |
| GPPGPRENQGPAPQG | 786 | Q9C0J8 | |
| QQGPPQGSLGPPPQG | 861 | Q9C0J8 | |
| GPPPLIPGLGQQGAQ | 926 | Q9C0J8 | |
| GRIPPLNPGQGPGPN | 941 | Q9C0J8 | |
| QGGELGAPGNLQPPP | 321 | P0DV75 | |
| LPGHGLQPPQGPPGG | 3636 | O14686 | |
| PQLGGFPGPQTGPLQ | 4261 | O14686 |